View patent here
ChemoCentryx Granted U.S. Patent #11,142,521 ‘Substituted anilines as CCR(4) antagonists’
View patent here
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
All news is property of their respective owners.
